Erasca, Inc. (ERAS)
17.61
-0.02
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
17.61
0.00 (0.00%)
After-Hours: 19:52
Erasca Shareholders Equity (Quarterly) : 361.87M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 361.87M |
| March 31, 2026 | 393.53M |
| December 31, 2025 | 325.17M |
| September 30, 2025 | 347.89M |
| June 30, 2025 | 372.26M |
| March 31, 2025 | 399.50M |
| December 31, 2024 | 423.50M |
| September 30, 2024 | 450.04M |
| June 30, 2024 | 451.09M |
| March 31, 2024 | 288.41M |
| December 31, 2023 | 316.69M |
| September 30, 2023 | 338.98M |
| Date | Value |
|---|---|
| June 30, 2023 | 362.70M |
| March 31, 2023 | 386.45M |
| December 31, 2022 | 411.85M |
| September 30, 2022 | 365.32M |
| June 30, 2022 | 395.07M |
| March 31, 2022 | 424.66M |
| December 31, 2021 | 456.53M |
| September 30, 2021 | 482.99M |
| June 30, 2021 | 190.80M |
| March 31, 2021 | 211.54M |
| December 31, 2020 | 107.42M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.606B |
| Tango Therapeutics, Inc. | 1.025B |
| Cogent Biosciences, Inc. | 532.39M |
| Apogee Therapeutics, Inc. | 1.195B |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 435.05M |
| Total Liabilities (Quarterly) | 73.18M |
| Debt to Equity Ratio | 0.1236 |
| Current Ratio | 8.294 |
| Net Debt Paydown Yield | 0.02% |